WellAdapt® Inc., the first digital health hypertension therapeutic company, is developing solutions to reduce the risks associated with hypertension and other chronic diseases. WellAdapt aspires to help patients gain greater control of their health while reducing medications, hospitalizations, and unnecessary doctor visits. The Cardiowell App supports devices that measure cardiac function allowing for a better understanding of current and future states of health and wellness.

WellAdapt Team


Our Mission is to enable people to live longer by increasing awareness, consciousness and wellbeing.

Our Vision is to see people live well and better-taken care of while relying on less medication.


Philosophy: We believe by coupling remote vital sign monitoring with increased self awareness and physiological regulation  you can better manage your blood pressure and improve your health and wellness*. 

Evidence: Research has shown that slow diaphragmatic breathing can reduce blood pressure by as much as 13.7/8.4 mmHg.  Breathing at six breathes per minute has been show to improve nervous system functioning  including improving depression and irritable bowel syndrome and reducing anxiety.  

The 2015 Systolic Blood Pressure Intervention Trial (SPRINT), found that having a more intensive systolic blood pressure (SBP) goal of 120 mmHg in patients at high risk for cardiovascular disease reduced both cardiovascular events and mortality by about 25%, compared with the current goal of 140 mmHg.    

Learn more

Our Goal is to help you live a longer and happier life

Cardiowell promotes mindfulness and physiological auto regulation, which, as part of a healthy lifestyle, may help reduce the risk of high blood pressure. 


Office Address

315 Meigs Rd. Suite A385
Santa Barbara CA  93105


*Cardiowell is a general wellness improvement solution to reduce the risks associated with hypertension. The Cardiowell solution is indicated for use only as an adjunctive treatment for high blood pressure together with other pharmacological and/or non-pharmacological interventions. Cardiowell recommends that you do not modify your hypertension treatments without the advice and consent of your physician.

Certain statements contained in this press release may be forward-looking statements. These statements may be identified by the use of forward-looking terminology such as “aspires” "goal”, “help”,  “based” " could" "expect” "predict," “soon” or "will" or other similar terminology.  We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these are reasonable, such forward- looking statements involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results to differ materially from any future results expressed or implied by these forward-looking statements. WellAdapt disclaims any intention or obligation to update or revise any forward-looking statements.